Form 4: Owens & Minor EVP, CEO of Patient Direct, Perry A. Bernocchi, Reports Acquisition and Disposal of Common Stock

Perry A. Bernocchi, EVP, CEO of Patient Direct at Owens & Minor, reports acquiring and disposing of common stock on March 3, 2025, according to a Form 4 filing.

Summary

• On March 3, 2025, Perry A. Bernocchi, EVP, CEO of Patient Direct at Owens & Minor, reported a transaction involving the company's common stock.
• Bernocchi acquired 123,391 shares of common stock at $0.
• Simultaneously, Bernocchi disposed of 252,911 shares.
• Following these transactions, Bernocchi beneficially owns 252,911 shares of Owens & Minor common stock.
• The acquisition involved a restricted stock grant which vests one-third per year over three years.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the disposal of shares could raise concerns, the acquisition of restricted stock suggests a continued commitment to the company. The overall impact is likely minimal.

Positives

• The acquisition of restricted stock indicates a long-term commitment by the executive to the company's success.

Negatives

• The disposal of 252,911 shares could be perceived negatively by investors, although the acquisition of restricted stock mitigates this concern.

Risks

• The disposal of a significant number of shares by an executive could create uncertainty among investors.

Future Outlook

The vesting schedule of the restricted stock grant suggests a multi-year commitment from the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The transactions themselves don't necessarily indicate a trend in the industry.

Stakeholder Impact

• The stock transaction may have a minor impact on shareholder sentiment.

Key Dates